Skip to main content
Clinical Trials/NCT03876860
NCT03876860
Recruiting
Not Applicable

An Enhanced Vaginal Dilator Model to Improve Patient Adherence and Reduce Radiation-Induced Vaginal Stenosis: a Randomized Control Trial

Margaret Liotta1 site in 1 country118 target enrollmentSeptember 24, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Endometrial Cancer
Sponsor
Margaret Liotta
Enrollment
118
Locations
1
Primary Endpoint
Participant Adherence
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This is a randomized control trial aimed to decreased radiation-induced vaginal stenosis in patients with endometrial or cervical cancer treated with post-operative external beam radiation therapy with or without brachytherapy. The intervention is an enhanced vaginal dilator model, including a silicone band placed at the desired depth of dilator insertion. The new model will be compared against the traditional vaginal dilator model used as our institutional standard of care. We hypothesize the enhanced model will improve adherence, correct use and efficacy of vaginal dilator use.

Detailed Description

Pelvic radiotherapy and vaginal brachytherapy play an integral role in managing gynecological malignancies, including endometrial and cervical cancer. Radiation-induced vaginal stenosis is a well recognized complication of radiation therapy and can result in painful, inadequate pelvic exams and sexual dysfunction. Current recommendations to prevent and manage vaginal stenosis include regular use of vaginal dilators, with our institutional recommendation being three times weekly for 10 minutes. Compliance varies among studies but is generally perceived to be low. Limited literature exists regarding ways to improve adherence and correct use of vaginal dilators. The goal of this study is to enhance the standard vaginal dilator model to improve patient outcomes. Eligibility includes women with endometrial or cervical cancer treated with post-operative external beam radiation therapy with or without brachytherapy. Patients will be randomized to either the standard vaginal dilator or an enhanced model. The enhanced dilator model includes the addition of a silicone band placed at the desired depth of vaginal dilator insertion, aimed to aide in correct insertion length. The primary aim of the study is patient adherence to vaginal dilator use. Secondary aims include vaginal length, CTCAE v5.0 grading scale for vaginal stricture, sexual function, self-reported comfort with use, and discomfort during office pelvic exams. Outcomes will be obtained based on physician reporting and patient surveys. All analyses will be completed by a biostatistician in the Clinical Research Office using SAS version 9.4.

Registry
clinicaltrials.gov
Start Date
September 24, 2018
End Date
April 1, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Margaret Liotta
Responsible Party
Sponsor Investigator
Principal Investigator

Margaret Liotta

Assistant Professor

Loyola University

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of endometrial or cervical cancer
  • Undergoing external beam radiation therapy with or without brachytherapy
  • English-speaking

Exclusion Criteria

  • History or current presence of fistula

Outcomes

Primary Outcomes

Participant Adherence

Time Frame: 12 months

Number of participants who use the vaginal dilator at least three times per week

Secondary Outcomes

  • Discomfort with dilator use(12 months)
  • Vaginal stenosis grading scale(12 months)
  • Change in female sexual function(12 months)
  • Vaginal Length(12 months)
  • Discomfort with pelvic exams(12 months)

Study Sites (1)

Loading locations...

Similar Trials